HOLMDEL, NEW JERSEY - June 16, 2026 – ETHERFAX, the leading provider of secure document exchange and cloud fax solutions, announced a strategic investment led by Telegraph Hill Partners (THP). As the only
CAMBRIDGE, Mass. and SAN FRANCISCO, Calif., – April 07, 2026 – Kytopen Corp., a leader in non-viral, continuous flow cellular engineering, today announced a Series
Greenville, SC and Sacramento, CA – PAI Pharma (“PAI”), a portfolio company of Olympus Partners and a leading U.S. developer, manufacturer and marketer of oral
Top-Cited TMS Brain Research Technology Enhanced for Next-Generation Neuromodulation MINNEAPOLIS, July 09, 2025 (GLOBE NEWSWIRE) The FDA has cleared the new Magstim Rapid TMS system
MIAMI, April 22, 2025 (Newswire.com) – Promptly, the leading All-in-One Patient Experience Suite, today announced the strategic acquisition of MDprospects and Patient Spectrum, which includes MDprospects™,
BILLERICA, Mass. and MARLBOROUGH, Mass.–Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, and Akoya Biosciences (NASDAQ: AKYA), The Spatial Biology
Proposed acquisition adds Nimble’s lead asset, an investigational oral peptide IL23R inhibitor in preclinical development for psoriasis, and a pipeline of other novel oral peptide
Miami, FL – Promptly Technology, Inc., a leader in streamlining patient engagement, secured strategic minority investments led by Telegraph Hill Partners. This growth capital will
PHILADELPHIA, April 1, 2024 /PRNewswire/ — ObservSMART, a leading proximity-based technology system for ensuring patient safety in healthcare settings, proudly announces the accomplishment of reaching 1
EditCo is focused on the development and manufacture of highly optimized CRISPR guide RNA designs and edited cells for the global cell biology and gene
Company Announces Appointment of Daniel Flynn, Ph.D. and Brian Cali, Ph.D. to Strengthen Capabilities in Support of Company’s Peptide Drug Programs MADISON, Wis.–(BUSINESS WIRE)–Nimble Therapeutics
Investment strengthens Argonaut’s leadership position in sterile fill / finish and expands the Company’s aseptic drug product manufacturing capabilities in pre-filled syringes and cartridges Carlsbad,
This website uses cookies and similar technologies to support basic site functionality and help us understand how visitors use the site. We use analytics tools such as Google Analytics, to improve website performance and content.We do not sell personal information or use cookies for targeted advertising.You can accept all cookies, reject non-essential cookies, or adjust your preferences at any time. For more information, please review our Privacy Policy.
Essential cookies and services enable basic functions and are necessary for the proper functioning of the website.
This category includes all cookies, domains, and services that do not fall into the other specified categories or have not been explicitly categorized.
This website uses cookies to enhance your browsing experience and ensure the site functions properly. By continuing to use this site, you acknowledge and accept our use of cookies.
